Advent Life Sciences — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Emergent Biosolutionsemergentbiosolutions.com in 𝕏NYSE: EBSOct 2018

Emergent BioSolutions is a public health company that develops, manufactures, and supplies medical countermeasures for national security and preparedness, along with commercialized products addressing threats such as the opioid epidemic.

Advanced ManufacturingBiotechHealthtechGaithersburg, US

Fuad El-Hibri(Director, Executive Officer)inRobert G Kramer(Executive Officer)inKatherine Strei(Executive Officer)Adam R Havey(Executive Officer)inDaniel J Abdun-Nabi(Executive Officer, Director)inJoseph C. Papa(President, CEO and Director)

Co-investorsOrbiMed

Macrolide Pharmaceuticals inMar 2018 · $20M

BiotechWatertown, US

Edward Mascioli(Executive Officer)Andrew Myers(Director)

BoardMarkus Goebel(Director)Henry Skinner(Director)inVikas Goyal(Director)

Board seatRaj Parekh· per SEC Form D

Co-investorsGurnet Point Capital Novartis Venture Fund Roche Venture Fund

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.